Searchable abstracts of presentations at key conferences in endocrinology

ea0028oc1.4 | Young Endocrinologists prize session | SFEBES2012

The thyroid hormone receptor-coactivator interface mediates negative feedback regulation of the human pituitary-thyroid axis

Moran Carla , Mitchell Catherine , Agostini Maura , Schoenmakers Erik , Gregory John , Gurnell Mark , Chatterjee Krishna

Corepressors and coactivators of thyroid hormone receptor-mediated function facilitate repression and transactivation of positively-regulated target genes respectively, but their role in negative regulation is not understood. A 13 yr old boy, born at 31 weeks gestation, was jittery at birth, with neonatal respiratory distress. Childhood features included poor weight gain, heat intolerance, tachycardia and hyperactivity. Ongoing problems are low frequency hearing loss, poor sig...

ea0021p313 | Reproduction | SFEBES2009

A simple modification of a commercial RIA to enable the more accurate measurement of serum testosterone in women

Montalto Joseph , McNeil Alan , Lim Chen-Fee , Lam Que , Mitchell David

The measurement of serum testosterone in women is difficult with most automated immunoassays because of poor sensitivity, accuracy and precision at low concentrations. Mass spectrometry is the gold standard for these measurements but it is slower and requires special expertise and equipment. We investigated whether the modification of a commercial RIA allowed improved testosterone measurements in laboratories without access to mass spectrometry.A commerc...

ea0019p146 | Diabetes, Metabolism and Cardiovascular | SFEBES2009

Metformin decreases angiogenesis via ERK1/2/ERK5 pathways by increasing the anti-angiogenic adipokine thrombospondin-1

Tan Bee , Kumar S Prashanth , Chen Jing , Heutling Dennis , Mitchell Dan , Lehnert Hendrik , Randeva Harpal

Aims: Polycystic ovary syndrome (PCOS) is associated with insulin resistance, obesity and cardiovascular complications. Thrombospondin-1 (TSP-1) is a novel anti-angiogenic adipokine highly expressed in obese, insulin-resistant subjects. We sought to assess TSP-1 levels in adipose (AT) from PCOS women and matched controls. The effects of metformin treatment on circulating TSP-1 levels in PCOS subjects; effects of serum from normal and PCOS women on in vitro migration and...

ea0015p251 | Pituitary | SFEBES2008

Metastatic deposits from a pituitary adenoma 36 years after an initial presentation

Karamat Muhammad Ali , Rangan Srinivasan , Ayuk John , Mitchell Rosalind , Gittoes Neil

Pituitary carcinoma is rare and diagnosis requires demonstration of cerebrospinal and/or systemic metastasis. We present case of a 64-year-old lady who presented with widespread spinal metastasis from a pituitary adenoma diagnosed 36 years ago. Our patient presented in 1971 with visual failure, headache and oligomenorrhoea. Imaging confirmed pituitary macroadenoma and she underwent transcranial hypophysectomy. Histology revealed chromophobe adenoma. Post operatively her vision...

ea0013p321 | Thyroid | SFEBES2007

Central arterial stiffness in resistance to thyroid hormone

Owen Penelope , John Rhys , Mitchell Catherine , Curran Suzanne , Chatterjee Krishna , Lazarus John

Resistance to thyroid hormone (RTH) is a rare, autosomal dominant disorder characterised by a reduced sensitivity of peripheral tissues to thyroid hormone. Thyroid function testing shows elevation of free T4 and T3 with non suppressed TSH levels.Vascular function in these patients has not been fully evaluated. We have studied central arterial stiffness in a cohort of RTH patients, comparing them with age and sex matched controls.Me...

ea0094p234 | Neuroendocrinology and Pituitary | SFEBES2023

The utility of routine fasting gut hormone assessment in asymptomatic individuals with Multiple Endocrine Neoplasia Type 1 (MEN1)

Muhammad Tahir Chohan Dr , Chris Boot Dr , Anna L Mitchell Dr

Background: Secretory pancreatic neuroendocrine tumours (PanNET) are common in MEN1. The MEN1 Clinical Practice guideline (Thakker, 2012) recommends annual assessment of fasting gut hormones (FGH) with annual pancreatic imaging for routine NET surveillance in MEN1.Study aim: To determine whether FGH (gastrin, glucagon, somatostatin, pancreatic polypeptide, VIP, insulin, chromogranin-A) in a cohort of asymptomatic individ...

ea0094p245 | Neuroendocrinology and Pituitary | SFEBES2023

A challenging case of recurrent cushings disease

Minhas Raisa , Vainieri Erika , Mitchell Catherine , Ling Yong , Tarigopula Giridhar , Wernig Florian , Alansari Mustafa

A 45-year-old female developed clinical and biochemical recurrent Cushings’ Disease 2.5 years after transsphenoidal hypophysectomy for 2cm pituitary macroadenoma. Past medical history included Type 2 Diabetes mellitus, asthma, hypertension, grade 3 obesity, dyslipidaemia, depression and sleep apnoea. MRI showed residual pituitary tissue with left sphenoid sinus extension. MDT advised repeat transphenoidal surgery over radiotherapy due to presence of a clearly visible surg...

ea0050oc3.3 | Obesity, Diabetes Thyroid | SFEBES2017

The GLP-1R agonist exendin-4 reduces cerebrospinal fluid secretion and intracranial pressure

Botfield Hannah , Uldall Maria , Westgate Connar , Mitchell James , Hagen Snorre , Maria Gonzalez Ana , Hodson David , Jensen Rigmor , Sinclair Alexandra

Background: Current therapies for reducing raised intracranial pressure (ICP) in conditions such as idiopathic intracranial hypertension have limited efficacy and tolerability. As such, there is a pressing need to identify novel drugs. Glucagon-like peptide-1 receptor (GLP-1R) agonists are used to treat diabetes and promote weight loss but have also been shown to affect fluid homeostasis in the kidney. Here, we investigate whether exendin-4, a GLP-1R agonist, is able to modula...

ea0050oc3.3 | Obesity, Diabetes Thyroid | SFEBES2017

The GLP-1R agonist exendin-4 reduces cerebrospinal fluid secretion and intracranial pressure

Botfield Hannah , Uldall Maria , Westgate Connar , Mitchell James , Hagen Snorre , Maria Gonzalez Ana , Hodson David , Jensen Rigmor , Sinclair Alexandra

Background: Current therapies for reducing raised intracranial pressure (ICP) in conditions such as idiopathic intracranial hypertension have limited efficacy and tolerability. As such, there is a pressing need to identify novel drugs. Glucagon-like peptide-1 receptor (GLP-1R) agonists are used to treat diabetes and promote weight loss but have also been shown to affect fluid homeostasis in the kidney. Here, we investigate whether exendin-4, a GLP-1R agonist, is able to modula...

ea0086p352 | Neuroendocrinology and Pituitary | SFEBES2022

The heart bleeds – complex management of a patient with acromegaly, cardiomyopathy and mechanical mitral valve

Sharma Aditi , Nyunt Sandhi , Narula Kavita , Mitchell Catherine , Mendoza Nigel , Yong Yong , Hatfield Emma , Meeran Karim , Martin Niamh

A 44 year old gentleman presented to his local hospital with a two week history of fevers and rigors. Blood cultures were positive for Streptococcus oralis, and an echocardiogram confirmed new diagnosis of hypertrophic cardiomyopathy (HCM) complicated by mitral valve infective endocarditis (IE). Unfortunately, this required a mechanical mitral valve replacement (MVR) and he started warfarin (INR target 2.5-3.5). During his admission, he reported chronic headaches. An MRI brain...